Advertisement
Screener

G1 THERAPEUTICS, INC. Patents: Active

G1 THERAPEUTICS, INC. Active Patents

51 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2022-05-11: Application 17742315; Invention SUBSTITUTED 1',2'-DIHYDRO-3'H-SPIRO[CYCLOHEXANE-1,4'-PYRIMIDO[5',4':4,5]PYRROLO[2,1-c][1,2,4]TRIAZIN]-3'-ONES AS CYCLIN-DEPENDENT KINASE INHIBITORS; Applicant G1 Therapeutics, Inc.; Status Patented Case.
  • 2022-02-28: Application 17683146; Invention MORPHIC FORMS OF G1T38 AND METHODS OF MANUFACTURE THEREOF; Applicant G1 Therapeutics, Inc.; Status Patented Case.
  • 2021-04-21: Application 17236687; Invention MORPHIC FORMS OF TRILACICLIB AND METHODS OF MANUFACTURE THEREOF; Applicant G1 Therapeutics, Inc.; Status Patented Case.
  • 2021-04-05: Application 17222873; Invention TRANSIENT PROTECTION OF NORMAL CELLS DURING CHEMOTHERAPY; Applicant G1 Therapeutics, Inc.; Status Patented Case.
FiledApplicationInventionApplicantStatusGrantedPatentPublished asInventor nameInventor countryExaminer
2022-05-1117742315SUBSTITUTED 1',2'-DIHYDRO-3'H-SPIRO[CYCLOHEXANE-1,4'-PYRIMIDO[5',4':4,5]PYRROLO[2,1-c][1,2,4]TRIAZIN]-3'-ONES AS CYCLIN-DEPENDENT KINASE INHIBITORSG1 Therapeutics, Inc.Patented Case2023-05-0911643416US20220306644A1
Jay Copeland Strum
United States
WILLIS, DOUGLAS M
2022-02-2817683146MORPHIC FORMS OF G1T38 AND METHODS OF MANUFACTURE THEREOFG1 Therapeutics, Inc.Patented Case2024-11-1212139494US20230043305A1
Alexander Smith
Hannah S. White
Patricia Andres
Xufeng Sun
Lei Zhu
Petinka I. Vlahova
United States
United States
United States
United States
United States
United States
MCDOWELL, BRIAN E
2021-04-2117236687MORPHIC FORMS OF TRILACICLIB AND METHODS OF MANUFACTURE THEREOFG1 Therapeutics, Inc.Patented Case2024-12-1712168666US20210387993A1
Stephen Schneider
Alexander Smith
Hannah S. White
Jay Copeland Strum
Jaroslaw Mazurek
United States
United States
United States
United States
Netherlands
DAHLIN, HEATHER RAQUEL
2021-04-0517222873TRANSIENT PROTECTION OF NORMAL CELLS DURING CHEMOTHERAPYG1 Therapeutics, Inc.Patented Case2023-08-0811717523US20210299130A1
Jay Copeland Strum
John Emerson Bisi
Patrick Joseph Roberts
Francis Xavier Tavares
United States
United States
United States
United States
TRAN, MY CHAU T
2021-02-2417184354SYNTHESIS OF 1,4-DIAZASPIRO[5.5]UNDECAN-3-ONEG1 Therapeutics, Inc.Patented Case2023-07-2511708337US20210179567A1
Stephen E. Schneider
Hannah White
Thomas Fessard
Sagar Beldar
United States
United States
Switzerland
Switzerland
RAO, DEEPAK R
2021-02-2217181638HSPC-SPARING TREATMENTS FOR RB-POSITIVE ABNORMAL CELLULAR PROLIFERATIONG1 Therapeutics, Inc.Patented Case2023-05-2311654148US20210213022A1
Jay Copeland Strum
John Emerson Bisi
Patrick Joseph Roberts
Francis X. Tavares
United States
United States
United States
United States
TRAN, MY CHAU T
2020-12-1417121392SYNTHESIS OF N-(HETEROARYL)-PYRROLO[3,2-D]PYRIMIDIN-2-AMINESG1 Therapeutics, Inc.Patented Case2023-04-1811629150US20210122755A1
Alexander Smith
Hannah S. White
Francis Xavier Tavares
Sergiy Krasutsky
Jian-Xie Chen
Roberta L. Dorrow
Hua Zhong
United States
United States
United States
United States
United States
United States
United States
YOO, SUN JAE
2020-11-1317097854MORPHIC FORMS OF TRILACICLIB AND METHODS OF MANUFACTURE THEREOFG1 Therapeutics, Inc.Patented Case2021-04-2710988479
Stephen Schneider
Alexander Smith
Hannah S. White
Jay Copeland Strum
Jaroslaw Mazurek
United States
United States
United States
United States
Netherlands
ZHANG, YANZHI
2020-07-0816924033G1T38 SUPERIOR DOSAGE REGIMESG1 Therapeutics, Inc.Patented Case2022-06-1411357779US20200405721A1
Andrew Beelen
Jay Copeland Strum
United States
United States
LEESER, ERICH A
2020-05-2816886309TRANSIENT PROTECTION OF NORMAL CELLS DURING CHEMOTHERAPYG1 Therapeutics, Inc.Patented Case2021-06-2211040042US20200345742A1
Jay Copeland Strum
John Emerson Bisi
Patrick Joseph Roberts
Francis Xavier Tavares
United States
United States
United States
United States
TRAN, MY CHAU T
2020-05-1315931330CDK INHIBITORSG1 Therapeutics, Inc.Patented Case2021-02-2310927120US20200277300A1
Francis X. Tavares
Jay Copeland Strum
United States
United States
MURRAY, JEFFREY H
2019-12-1916721631MORPHIC FORMS OF G1T38 AND METHODS OF MANUFACTURE THEREOFG1 Therapeutics, Inc.Patented Case2022-03-0111261193US20200123168A1
Alexander Smith
Hannah S. White
Patricia Andres
Xufeng Sun
Lei Zhu
Petinka I. Vlahova
United States
United States
United States
United States
United States
United States
MCDOWELL, BRIAN E
2019-09-1616572418TREATMENT OF RB-NEGATIVE TUMORS USING TOPOISOMERASE INHIBITORS IN COMBINATION WITH CYCLIN DEPENDENT KINASE 4/6 INHIBITORSG1 Therapeutics, Inc.Patented Case2021-08-1711090306US20200022983A1
Jay Copeland Strum
John E. Bisi
Patrick Joseph Roberts
Jessica A. Sorrentino
United States
United States
United States
United States
SCHMITT, MICHAEL J
2019-06-0516432244PRESERVATION OF IMMUNE RESPONSE DURING CHEMOTHERAPY REGIMENSG1 Therapeutics, Inc.Patented Case2022-12-2011529352US20190321370A1
Jessica A. Sorrentino
Anne Y. Lai
Jay C. Strum
Patrick Joseph Roberts
United States
United States
United States
United States
PUTTLITZ, KARL J
2019-01-2216254364ANTI-NEOPLASTIC COMBINATIONS AND DOSING REGIMENS USING CDK4/6 INHIBITOR COMPOUNDS TO TREAT RB-POSITIVE TUMORSG1 Therapeutics, Inc.Patented Case2022-09-2011446295US20190151311A1
Jay Copeland Strum
John E. Bisi
Patrick Joseph Roberts
Jessica A. Sorrentino
Hannah S. White
United States
United States
United States
United States
United States
RAMACHANDRAN, UMAMAHESWARI
2018-12-2116230412PYRIMIDINE-BASED COMPOUNDS FOR THE TREATMENT OF CANCERG1 Therapeutics, Inc.Patented Case2020-04-1410618905US20190119294A1
Jay Copeland Strum
United States
PAGANO, ALEXANDER R
2018-12-2116230396SUBSTITUTED DIHYDROPYRAZINO[1',2':1,5]PYRROLO[2,3-d]PYRIMIDINE-BASED ANTIPROLIFERATIVE AGENTSG1 Therapeutics, Inc.Patented Case2020-11-1010829490US20190135811A1
Jay Copeland Strum
David Jung
United States
United States
WILLIS, DOUGLAS M
2018-12-2116230388ANTIPROLIFERATIVE PYRIMIDINE-BASED COMPOUNDSG1 Therapeutics, Inc.Patented Case2020-05-1910654831US20190135784A1
Jay Copeland Strum
Ricky D. Gaston
Robert C. Gadwood
United States
United States
United States
SACKEY, EBENEZER O
2018-12-2116230381SYNTHESIS OF N-(HETEROARYL)-PYRROLO[3,2-D]PYRIMIDIN-2-AMINESG1 Therapeutics, Inc.Patented Case2020-12-1510865210US20190135820A1
Alexander Smith
Hannah S. White
francis Xavier Tavares
Sergiy Krasutsky
Jian-Xie Chen
Roberta L. Dorrow
Hua Zhong
United States
United States
United States
United States
United States
United States
United States
YOO, SUN JAE
2018-12-2016228308Highly Active Anti-Neoplastic and Anti-Proliferative AgentsG1 Therapeutics, Inc.Patented Case2020-07-1410709711US20190125752A1
Jay Copeland Strum
John Emerson Bisi
Patrick Joseph Roberts
Francis Xavier Tavares
United States
United States
United States
United States
JEAN-LOUIS, SAMIRA JM
2018-12-1916226430CDK INHIBITORSG1 Therapeutics, Inc.Patented Case2020-06-3010696682US20190119292A1
Francis X. Tavares
Jay Copeland Strum
United States
United States
MURRAY, JEFFREY H
2018-11-0116178419HSPC-SPARING TREATMENTS FOR RB-POSITIVE ABNORMAL CELLULAR PROLIFERATIONG1 Therapeutics, Inc.Patented Case2021-02-2310925878US20190070185A1
Jay Copeland Strum
John Emerson Bisi
Patrick Joseph Roberts
Francis Xavier Tavares
United States
United States
United States
United States
TRAN, MY CHAU T
2018-09-2616142574TREATMENT OF RB-NEGATIVE TUMORS USING TOPOISOMERASE INHIBITORS IN COMBINATION WITH CYCLIN DEPENDENT KINASE 4/6 INHIBITORSG1 Therapeutics, Inc.Patented Case2019-09-1710413547US20190030034A1
Jay Copeland Strum
John E. Bisi
Patrick Joseph Roberts
Jessica A. Sorrentino
United States
United States
United States
United States
CHU, YONG LIANG
2018-08-2416112362HSPC-SPARING TREATMENTS FOR RB-POSITIVE ABNORMAL CELLULAR PROLIFERATIONG1 Therapeutics, Inc.Patented Case2019-10-0810434104US20180360841A1
Jay Copeland Strum
John Emerson Bisi
Patrick Joseph Roberts
Francis Xavier Tavares
United States
United States
United States
United States
TRAN, MY CHAU T
2018-08-2416112360TRANSIENT PROTECTION OF NORMAL CELLS DURING CHEMOTHERAPYG1 Therapeutics, Inc.Patented Case2021-04-0610966984US20180360840A1
Jay Copeland Strum
John Emerson Bisi
Patrick Joseph Roberts
Francis Xavier Tavares
United States
United States
United States
United States
TRAN, MY CHAU T
2018-04-0215943278TRANSIENT PROTECTION OF NORMAL CELLS DURING CHEMOTHERAPYG1 Therapeutics, Inc.Patented Case2020-05-2610660896US20180221378A1
Jay Copeland Strum
John Emerson Bisi
Patrick Joseph Roberts
Francis X. Tavares
United States
United States
United States
United States
TRAN, MY CHAU T
2018-03-1215918877CDK INHIBITORSG1 Therapeutics, Inc.Patented Case2019-01-2910189851US20180201619A1
Francis X. Tavares
Jay C. Strum
United States
United States
MURRAY, JEFFREY H
2018-03-1215918852CDK INHIBITORSG1 Therapeutics, Inc.Patented Case2019-01-2910189850US20180201618A1
Francis X. Tavares
Jay C. Strum
United States
United States
MURRAY, JEFFREY H
2018-03-1215918834CDK InhibitorsG1 Therapeutics, Inc.Patented Case2019-01-2910189849US20180201617A1
Francis X. Tavares
Jay C. Strum
United States
United States
MURRAY, JEFFREY H
2018-01-0215860483LACTAM KINASE INHIBITORSG1 Therapeutics, Inc.Patented Case2019-11-0510464940US20180127431A1
Francis Xavier Tavares
United States
PATEL, SAGAR S
2017-07-3115665071TRICYCLIC LACTAMS FOR USE IN HSPC-SPARING TREATMENTS FOR RB-POSITIVE ABNORMAL CELLULAR PROLIFERATIONG1 Therapeutics, Inc.Patented Case2019-08-1310376519US20170333440A1
Jay Copeland Strum
John Emerson Bisi
Patrick Joseph Roberts
Ricky D. Gaston
Robert C. Gadwood
United States
United States
United States
United States
United States
JEAN-LOUIS, SAMIRA JM
2017-03-1315457699ANTI-NEOPLASTIC COMBINATIONS AND DOSING REGIMENS USING CDK4/6 INHIBITOR COMPOUNDS TO TREAT RB-POSITIVE TUMORSG1 Therapeutics, Inc.Patented Case2019-03-1910231969US20170182043A1
Jay Copeland Strum
John E. Bisi
Patrick Joseph Roberts
Jessica A. Sorrentino
Hannah S. White
United States
United States
United States
United States
United States
KATAKAM, SUDHAKAR
2016-12-2115387083HSPC-Sparing Treatments for RB-Positive Abnormal Cellular ProliferationG1 Therapeutics, Inc.Patented Case2018-09-1810076523US20170100405A1
Jay Copeland Strum
John Emerson Bisi
Patrick Joseph Roberts
Francis Xavier Tavares
United States
United States
United States
United States
TRAN, MY CHAU T
2016-11-1015348862LACTAM KINASE INHIBITORSG1 Therapeutics, Inc.Patented Case2018-01-029856268US20170057972A1
Francis Xavier Tavares
United States
PATEL, SAGAR S
2016-11-1015348770CDK InhibitorsG1 THERAPEUTICS, INC.Patented Case2018-05-019957276US20170057971A1
Francis X. Tavares
Jay C. Strum
United States
United States
MURRAY, JEFFREY H
2016-11-0315342990Transient Protection of Normal Cells During ChemotherapyG1 THERAPEUTICS, INC.Patented Case2018-10-0210085992US20170065597A1
Jay Copeland Strum
John Emerson Bisi
Patrick Joseph Roberts
Francis Xavier Tavares
United States
United States
United States
United States
TRAN, MY CHAU T
2016-10-0715288878TRANSIENT PROTECTION OF NORMAL CELLS DURING CHEMOTHERAPYG1 Therapeutics, Inc.Patented Case2018-04-039931345US20170037051A1
Jay Copeland Strum
John Emerson Bisi
Patrick Joseph Roberts
Francis Xavier Tavares
United States
United States
United States
United States
TRAN, MY CHAU T
2015-12-2914982443Lactam Kinase InhibitorsG1 Therapeutics, Inc.Patented Case2017-08-299745316US20160108054A1
Francis Xavier Tavares
United States
PATEL, SAGAR S
2015-05-1414712630CDK InhibitorsG1 Therapeutics, Inc.Patented Case2016-11-019481691US20150246926A1
Francis X. Tavares
Jay C. Strum
United States
United States
MURRAY, JEFFREY H
2015-05-1414712582CDK InhibitorsG1 Therapeutics, Inc.Patented Case2016-11-229499564US20150246925A1
Francis X. Tavares
Jay C. Strum
United States
United States
MURRAY, JEFFREY H
2015-04-1714690180Tricyclic Lactams for Use in HSPC-Sparing Treatments for RB-Positive Abnormal Cellular ProliferationG1 THERAPEUTICS, INC.Patented Case2017-08-019717735US20150299212A1
Jay Copeland Strum
John Emerson Bisi
Patrick Joseph Roberts
Ricky D. Gaston
Robert C. Gadwood
United States
United States
United States
United States
United States
JEAN-LOUIS, SAMIRA JM
2014-09-2614498796LACTAM KINASE INHIBITORSG1 Therapeutics, Inc.Patented Case2016-02-169260442US20150018348A1
Francis Xavier Tavares
United States
PATEL, SAGAR S
2014-08-0514452296CDK InhibitorsG1 Therapeutics, Inc.Patented Case2015-08-119102682US20150031880A1
Francis X. Tavares
Jay C. Strum
United States
United States
MASHA, OLUWAFEMI L
2014-03-1414214048HSPC-Sparing Treatments for RB-Positive Abnormal Cellular ProliferationG1 THERAPEUTICS, INC.Patented Case2016-12-279527857US20140271466A1
Jay Copeland Strum
John Emerson Bisi
Patrick Joseph Roberts
Francis Xavier Tavares
United States
United States
United States
United States
TRAN, MY CHAU T
2014-03-1414212911Transient Protection of Normal Cells During ChemotherapyG1 Therapeutics, Inc.Patented Case2016-10-119464092US20140275067A1
Jay Copeland Strum
John Emerson Bisi
Patrick Joseph Roberts
Francis Xavier Tavares
United States
United States
United States
United States
TRAN, MY CHAU T
2014-03-1414212430Transient Protection of Normal Cells During ChemotherapyG1 Therapeutics, Inc.Patented Case2016-11-089487530US20140275066A1
Jay Copeland Strum
John Emerson Bisi
Patrick Joseph Roberts
Francis Xavier Tavares
United States
United States
United States
United States
TRAN, MY CHAU T
2014-01-2314162649CDK INHIBITORSG1 Therapeutics, Inc.Patented Case2014-09-028822683US20140142299A1
Francis X. Tavares
Jay C. Strum
United States
United States
MASHA, OLUWAFEMI L
2014-01-2314162637CDK INHIBITORSG1 Therapeutics, Inc.Patented Case2014-09-098829012US20140142306A1
Francis X. Tavares
Jay C. Strum
United States
United States
MASHA, OLUWAFEMI L
2013-04-2413869594CDK INHIBITORSG1 THERAPEUTICS, INC.Patented Case2014-04-088691830US20130237534A1
Francis X. Tavares
Jay C. Strum
United States
United States
MASHA, OLUWAFEMI L
2013-04-2413869576CDK INHIBITORSG1 THERAPEUTICS, INC.Patented Case2013-12-038598197US20130237533A1
Francis X. Tavares
Jay C. Strum
United States
United States
MASHA, OLUWAFEMI L
2013-04-2413869520CDK INHIBITORSG1 THERAPEUTICS, INC.Patented Case2013-12-038598186US20130237544A1
Francis X. Tavares
Jay C. Strum
United States
United States
MASHA, OLUWAFEMI L